ERA

Download the full-sized PDF of Health Technology Management and Canada's Medical Devices Special Access ProgramDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3ZG6GN0Z

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Health Technology Management and Canada's Medical Devices Special Access Program Open Access

Descriptions

Other title
Subject/Keyword
medical devices
Canada
health technology management
special access program
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Maier, Roland K
Supervisor and department
Menon, Devidas (School of Public Health)
Examining committee member and department
Juzwishin, Don
Welsh, Rob
Stafinski, Tania (School of Public Health)
Department
School of Public Health
Specialization
Health Technology Assessment
Date accepted
2017-09-21T10:17:16Z
Graduation date
2017-11:Fall 2017
Degree
Master of Science
Degree level
Master's
Abstract
Health Technology Management (HTM) encompasses a broad array of processes spanning technical, clinical, and administrative disciplines in order to optimize the efficient use of healthcare resources. It employs a ‘lifecycle’ approach, evaluating technologies at each stage of maturity from concept through use and finally discontinuance. Health technologies exist in various forms; one of them being medical devices. In Canada, medical devices are controlled through the federal Food and Drugs Act and Regulations. While most medical devices require licensing to be sold in the market, provisions exist in the regulations for healthcare professionals to access unlicensed devices. One mechanism is through application to Health Canada’s Medical Devices Special Access Program (MDSAP). This thesis examined the MDSAP in order to understand its role in HTM. Three separate, yet related studies, were conducted. The first study employed a scoping literature review to determine the landscape of available information and to identify more focused areas of required research. The second study reviewed two cases to determine why and how the MDSAP was used to obtain devices in a hospital setting. The third study conducted key informant interviews to compare and contrast key stakeholder perspectives on roles and responsibilities, knowledge and information needs, and program utilization. Each study employed qualitative content analysis to generate findings. The scoping study determined that the literature was generally limited, yet suggested the MDSAP roles in HTM are: as an arbiter in technology selection, as a route to technology procurement, and as a facilitator of health technology innovation. The two-case study determined the MDSAP was used for the introduction of new health technology, which comprised 5 general processes: Technology Development, Knowledge Transfer, Evaluation, Acquisition, and Patient Management, and the program played an essential role in the Acquisition stage for the two novel technologies under consideration. Four drivers of program use were identified. These were: change agents, clinical need, innovation, and new evidence. The combination of driving forces triggered the sequence of processes. The MDSAP is a regulatory policy that impacts the management of health technology. It can result in the accelerated replacement of existing technology, organizational change, and innovation in the development of best clinical practice. The study on stakeholder produced four themes: the MDSAP authorizes access to needed medical devices, physicians drive MDSAP demand in the interest of patient care, global forces impact the MDSAP, and the improved management of health technology is a priority need. This study suggests HTM’s next steps should include initiatives that enhance the collection and dissemination of unlicensed medical device data. The three studies’ findings were aligned. They inform components of the four major stages of the technology lifecycle – premarket, adoption, real-world use, and decommissioning – and demonstrate the role and impact of the MDSAP in HTM.
Language
English
DOI
doi:10.7939/R3ZG6GN0Z
Rights
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication

File Details

Date Uploaded
Date Modified
2017-09-21T16:17:16.896+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (PDF/A)
Mime type: application/pdf
File size: 1507005
Last modified: 2017:11:08 18:26:33-07:00
Filename: Maier_Roland_K_201709_MSc.pdf
Original checksum: 30dcd6b3848d4c137e292ead10580c5f
Activity of users you follow
User Activity Date